Is a complete PDSB research report available?

No complete published report is available for PDS Biotechnology Corporation (PDSB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

PDS Biotechnology Corporation (PDSB)

NASDAQ: PDSB · USD

$0.68

-0.02 (-2.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PDSB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	38M
Net income (ttm)	-33.4M
EPS (ttm)	-$0.67
Shares out	55.8M
Volume	202,049
Beta	1.58
Price target	$7.50	+1000.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -33.4M
EPS (ttm): -$0.67
Market cap: 38M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PDSB indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001472091
Company name	PDS Biotechnology Corporation
Country	United States
Country code	US
Cusip	70465T107
Employees	21
Employees Change	-3%
Employees Change Percent	-12.5
Enterprise value	$32.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US70465T1079
Last refreshed	2026-07-26
Market cap	$38M
Market cap category	Nano-Cap
Price	$0.68
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	PDSB
Website	https://www.pdsbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-87.7%
FCF yield	-60.71%
P/B ratio	9.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-33.4M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Profit Per Employee	$-1.6M
ROA	-50.49
Roa5y	-39.64
ROCE	-199.5
ROE	-254.1
Roe5y	-129.4
ROIC	-59.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.51%
Cagr3y	-49.87%
Cagr5y	-41.43%
EPS Growth Quarters	10
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$24.7M
Cash	$21.7M
Current Assets	$22.9M
Current Liabilities	$10.1M
Debt	$15.9M
Debt Equity	$4.07
Equity	$3.9M
Interest Coverage	-5.34
Liabilities	$20.8M
Long Term Assets	$1.8M
Long Term Liabilities	$10.6M
Net Cash	$5.8M
Net Cash By Market Cap	$15.25
Net Cash Growth	-72.41%
Net Debt Equity	$-1.49
Tangible Book Value	$3.9M
Tangible Book Value Per Share	$0.07
WACC	17.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.26
Net Working Capital	$-3.7M
Quick ratio	2.13
Working Capital	$12.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-32.34%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.49%
200-day SMA	0.89
3Y total return	-87.4%
50-day SMA	0.96
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.1%
All Time High	17.85
All Time High Change	-96.18%
All Time High Date	2021-09-24
All Time Low	0.51
All Time Low Change	34.45%
All Time Low Date	2026-03-31
ATR	0.07
Beta	1.58
Beta1y	4.1
Beta2y	2.89
Ch YTD	-11.48
High	0.71
High52	1.55
High52 Date	2026-05-14
High52ch	-56.04%
Low	0.67
Low52	0.51
Low52 Date	2026-03-31
Low52ch	34.45%
Ma50ch	-29.17%
Premarket Change Percent	0.93
Premarket Price	$0.71
Price vs 200-day SMA	-23.64%
RSI	31.99
RSI Monthly	38
RSI Weekly	41.4
Sharpe ratio	-0.17x
Sortino ratio	-0.2
Total Return	-32.34%
Tr YTD	-11.48
Tr1m	-25.29%
Tr1w	-7.28%
Tr3m	-26.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$9
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.13
Operating Income	$-29M
Price target	$7.5
Price Target Change	$1,001
Price Target Change Top	$1,221

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,404,262%
Float Percent	97.47%
Net Borrowing	-5,936,428
Shares Insiders	2.53%
Shares Institutions	9.4%
Shares Out	55,815,653
Shares Qo Q	7.57%
Shares Yo Y	32.34%
Short Float	2.46%
Short Ratio	1.75
Short Shares	2.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-27.1M
Average Volume	306,097.15x
Bv Per Share	0.07
Ch1m	-25.29
Ch1w	-7.28
Ch1y	-45.49
Ch3m	-26.58
Ch3y	-87.4
Ch5y	-93.1
Ch6m	-28.27
Change	-2.73%
Change From Open	-2.73
Close	0.7
Days Gap	0
Depreciation Amortization	60,518
Dollar Volume	137,676.2
Earnings Date	2026-08-12
Earnings Time	bmo
EBIT	$-29M
EBITDA	$-27.2M
EPS	$-0.67
F Score	1
FCF	$-23.1M
FCF EV Yield	-71.64x
FCF Per Share	$-0.41
Financing CF	4,773,224
Fiscal Year End	December
Founded	2,005
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2019-03-18
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.89
Ma150ch	-23.34%
Ma20	0.79
Ma20ch	-13.35%
Net CF	-18,318,178
Next Earnings Date	2026-08-12
Open	0.7
Optionable	Yes
Position In Range	28.11
Post Close	0.68
Postmarket Change Percent	0.1
Postmarket Price	$0.68
Ppne	228,569
Pre Close	0.7
Price Date	2026-07-24
Ptbv Ratio	9.77
Relative Volume	0.66x
Share Based Comp	4,009,219
Tr6m	-28.27%
Us State	New Jersey
Volume	202,049

PDS Biotechnology Corporation (PDSB)

Coverage state: Market snapshot only — no published research

Generate the first PDSB analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PDSB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PDSB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PDSB

Frequently asked questions